Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

NCT02525822 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: IDP-123 Lotion
DRUG: Tazorac Cream, 0.1%,
DRUG: Vehicle Cream
DRUG: Vehicle Lotion

Sponsor

Valeant Pharmaceuticals